Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT.

BACKGROUND AND PURPOSE Thrombolytic therapy was carried out on patients with acute ischemic stroke, and the risk of hemorrhagic transformation was evaluated from the residual cerebral blood flow (CBF) by pretherapeutic single-photon emission-computed tomography (SPECT). METHODS Local intra-arterial thrombolytic therapy was carried out using urokinase or recombinant tissue plasminogen activator (rt-PA) within 6 hours from the onset in 34 patients in whom no hypodensity areas were observed on the initial computed tomography examination. In the 20 patients with carotid territory occlusion who underwent 99mTc-labeled hexamethylpropyleneamine oxime (99mTc-HMPAO) SPECT, the residual CBF of the ischemic region was evaluated semiquantitatively by calculating two parameters: the ischemic regional activity to cerebellar activity ratio (R/CE ratio) and asymmetry index (AI). RESULTS The occluded vessels could be recanalized in 22 (92%) of the 24 patients in the urokinase group and in all 10 of the patients in the rt-PA group. Hemorrhagic transformation appeared in 4 patients in the urokinase group and 3 patients in the rt-PA group. Among the 20 patients who underwent SPECT before the treatment, the residual CBF was lower in the 5 patients who developed hemorrhagic transformation than in the 15 who did not (P < .05). Hemorrhagic transformation occurred in all patients with R/CE ratio of less than 0.35 and AI of more than 1.5. CONCLUSIONS The risk of hemorrhagic transformation after recanalization of occluded vessels by local intra-arterial thrombolytic therapy was considered to be high when the pretherapeutic residual CBF was markedly reduced.

[1]  J. Marler,et al.  Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset , 1992, Stroke.

[2]  J. Broderick,et al.  Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes , 1992, Stroke.

[3]  W. Hacke,et al.  Safety and Efficacy of Intravenous Tissue Plasminogen Activator and Heparin in Acute Middle Cerebral Artery Stroke , 1992, Stroke.

[4]  M. Fujishima,et al.  Early Computed Tomographic Findings for Thrombolytic Therapy in Patients With Acute Brain Embolism , 1992, Stroke.

[5]  W. Hacke,et al.  Thrombolytic Intervention in Acute Thrombotic and Embolic Stroke , 1991, Zeitschrift fur Kardiologie.

[6]  M. Pessin,et al.  Thrombolytic agents in the treatment of stroke. , 1990, Clinical neuropharmacology.

[7]  G. Boysen,et al.  Fatal ischaemic brain oedema after unsuccessful thrombolysis. , 1990, Neurological research.

[8]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[9]  P. Courtheoux,et al.  Local intraarterial fibrinolysis in the carotid territory. , 1989, AJNR. American journal of neuroradiology.

[10]  H. Hoshi,et al.  Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  Olaf B. Paulson,et al.  The Retention of [99mTc]-d,l-HM-PAO in the Human Brain after Intracarotid Bolus Injection: A Kinetic Analysis , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  M. Nobuyoshi,et al.  Randomized, double-blinded multicenter study. Comparison of intracoronary single-chain urokinase-type plasminogen activator, pro-urokinase (GE-0943), and intracoronary urokinase in patients with acute myocardial infarction. , 1988, Circulation.

[13]  Gregory,et al.  Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. , 1988, Stroke.

[14]  A. Yamadori,et al.  Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. , 1988, Stroke.

[15]  W. Hacke,et al.  Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study. , 1988, Stroke.

[16]  O B Paulson,et al.  Regional Cerebral Blood Flow Assessed by 133Xe Inhalation and Emission Tomography: Normal Values , 1985, Journal of computer assisted tomography.

[17]  T. Yoshimoto,et al.  Hemodynamics in hemorrhagic infarction--an experimental study. , 1983, Stroke.

[18]  T. Shima,et al.  Experimental microsurgical embolectomy after middle cerebral artery embolization in the dog. , 1983, Journal of neurosurgery.

[19]  A. Tamura,et al.  Correlation Between rCBF and Histological Changes Following Temporary Middle Cerebral Artery Occlusion , 1980, Stroke.

[20]  R. Ojemann,et al.  Cerebral Blood Flow Determined by Hydrogen Clearance During Middle Cerebral Artery Occlusion in Unanesthetized Monkeys , 1978, Stroke.

[21]  M. Dujovny,et al.  Middle cerebral artery microneurosurgical embolectomy. , 1976, Surgery.

[22]  M. Raichle,et al.  A Pilot Study of Urokinase Therapy in Cerebral Infarction , 1976, Stroke.

[23]  A. Ommaya,et al.  Temporary Occlusion of the Middle Cerebral Artery in the Monkey: Clinical and Pathological Observations , 1970, Stroke.

[24]  E. Möbius,et al.  Local Thrombolytic Therapy in Acute Basilar Artery Occlusion: Experience with 18 Patients , 1991 .

[25]  K. Matsumoto,et al.  Topical Intraarterial Urokinase Infusion for Acute Stroke , 1991 .

[26]  T. Hayakawa,et al.  Thrombolytic Therapy in Embolic and Thrombotic Cerebral Infarction: A Cooperative Study , 1991 .

[27]  E. Mori.  Fibrinolytic Recanalization Therapy in Acute Cerebrovascular Thromboembolism , 1991 .

[28]  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. , 1989, The New England journal of medicine.